Breaking News Instant updates and real-time market news.

TSLA

Tesla

$274.95 /

+7.205 (+2.69%)

07:28
04/08/19
04/08
07:28
04/08/19
07:28

Needham expects Tesla revenue to 'decelerate materially'

Needham analyst Rajvindra Gill kept his Underperform rating on Tesla and lowered his FY19 EPS view to $1.25 from $4.30 and FY20 to $4.90 from $8.25, after the company's 45% decline in Model S/X deliveries reported for Q1. The analyst contends that after a 200% revenue acceleration over the past 3 years, sales growth will decelerate materially to 12% in 2019 and 15% in 2020 from 83% in 2018. Gill expects investors to struggle with justifying a high valuation if overall sales growth continues to decelerate and margins remain under pressure.

  • 22

    Apr

TSLA Tesla
$274.95 /

+7.205 (+2.69%)

04/05/19 Vertical Group
Vertical Group says Tesla running out of car buyers, cuts price target to $54
04/04/19 RBC Capital
Tesla's Q1 deliveries imply $1B or more in revenue miss, says RBC Capital
04/04/19 Barclays
Tesla Q1 deliveries 'call hyper-growth into question,' says Barclays
04/04/19 Morgan Stanley
Tesla worsening mix biggest negative surprise from Q1, says Morgan Stanley

TODAY'S FREE FLY STORIES

Earnings
Physicians Realty Trust reports Q4 normalized FFO 27c, consensus 27c » 07:52
02/26/20
02/26
07:52
02/26/20
07:52
DOC

Physicians Realty Trust

$20.30 /

-0.36 (-1.74%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Unisys selected by European Fisheries Control Agency for IT services » 07:52
02/26/20
02/26
07:52
02/26/20
07:52
UIS

Unisys

$15.88 /

-0.405 (-2.49%)

Unisys is partnering with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta plans to initiate IND-enabling studies for M267 in 2020 » 07:52
02/26/20
02/26
07:52
02/26/20
07:52
MNTA

Momenta

$30.79 /

-1.09 (-3.42%)

Momenta's SIFbody…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta says CSL plans to introduce M230 Phase 1 program this year » 07:51
02/26/20
02/26
07:51
02/26/20
07:51
MNTA

Momenta

$30.79 /

-1.09 (-3.42%)

M230: a recombinant Fc…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Disney weakness on CEO change a buying opportunity says JPMorgan » 07:50
02/26/20
02/26
07:50
02/26/20
07:50
DIS

Disney

$128.24 /

-4.79 (-3.60%)

The timing of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta expects to report top-line data from Vivacity-MG study in 3Q20 » 07:50
02/26/20
02/26
07:50
02/26/20
07:50
MNTA

Momenta

$30.79 /

-1.09 (-3.42%)

Nipocalimab: a fully…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Morgan Stanley staying cautious on cruise lines, cuts EPS estimates and targets » 07:50
02/26/20
02/26
07:50
02/26/20
07:50
CCL

Carnival

$35.83 /

-1.95 (-5.16%)

, CUK

Carnival plc

$33.79 /

-1.91 (-5.35%)

, RCL

Royal Caribbean

$89.50 /

-7.03 (-7.28%)

, NCLH

Norwegian Cruise Line

$39.30 /

-3.32 (-7.79%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Freshpet price target raised to $70 from $45 at SunTrust » 07:50
02/26/20
02/26
07:50
02/26/20
07:50
FRPT

Freshpet

$74.53 /

+0.85 (+1.15%)

SunTrust analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27
    Feb
Recommendations
Jazz Pharmaceuticals lowered his price target to $165 from $200 at Cowen » 07:49
02/26/20
02/26
07:49
02/26/20
07:49
JAZZ

Jazz Pharmaceuticals

$127.50 /

-3.31 (-2.53%)

Cowen analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta expects to launch Phase 2 study of M254 in 4Q20 » 07:49
02/26/20
02/26
07:49
02/26/20
07:49
MNTA

Momenta

$30.79 /

-1.09 (-3.42%)

M254: a hypersialylated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Paramount Gold Nevada expects to complete modified CPA in 2Q20 » 07:47
02/26/20
02/26
07:47
02/26/20
07:47
PZG

Paramount Gold Nevada

$0.82 /

-0.1103 (-11.86%)

The Oregon Department of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Jacobs selected by USACE Environmental Quality Program » 07:47
02/26/20
02/26
07:47
02/26/20
07:47
J

Jacobs

$98.71 /

-3.275 (-3.21%)

Jacobs was selected by…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Paramount Gold Nevada submits mine plan of operation to Federal BLM » 07:47
02/26/20
02/26
07:47
02/26/20
07:47
PZG

Paramount Gold Nevada

$0.82 /

-0.1103 (-11.86%)

Paramount Gold Nevada…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Emerald Health's Pure Sunfarms makes first cannabis shipment to Alberta » 07:45
02/26/20
02/26
07:45
02/26/20
07:45
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

Emerald Health…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Jumia Technologies price target lowered to $13 from $22 at RBC Capital » 07:45
02/26/20
02/26
07:45
02/26/20
07:45
JMIA

Jumia Technologies

$3.98 /

-1.54 (-27.90%)

RBC Capital analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Treasury Market Outlook: The markets were choppy and mixed overnight » 07:45
02/26/20
02/26
07:45
02/26/20
07:45

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
U.S. MBA reported mortgage applications bounced 1.5% in the week ended February 21 » 07:45
02/26/20
02/26
07:45
02/26/20
07:45

U.S. MBA reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Fulcrum Therapeutics completes enrollment in Phase 2b trial of losmapimod » 07:44
02/26/20
02/26
07:44
02/26/20
07:44
FULC

Fulcrum Therapeutics

$16.22 /

-0.09 (-0.55%)

Fulcrum Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
eGain management to meet with Benchmark » 07:44
02/26/20
02/26
07:44
02/26/20
07:44
EGAN

eGain

$9.29 /

-0.48 (-4.91%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Wayfair price targetlowered to $110 from $130 at Cowen » 07:44
02/26/20
02/26
07:44
02/26/20
07:44
W

Wayfair

$71.68 /

-3.86 (-5.11%)

Cowen analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
JPMorgan nearly halves SmileDirectClub target after 'disappointing' results » 07:44
02/26/20
02/26
07:44
02/26/20
07:44
SDC

SmileDirectClub

$11.33 /

-0.51 (-4.31%)

JPMorgan analyst Robbie…

JPMorgan analyst Robbie Marcus nearly halved his price target on SmileDirectClub to $16 from $31 while keeping an Overweight rating on the shares. The stock in premarket trading is down 23%, or $2.64, to $8.69. The company last night posted "disappointing" Q4 results with sales of $197M coming in $3M below consensus, Marcus tells investors in a post-earnings research note. The results were driven by a lower than expected level of aligner sales, due primarily to manufacturing issues limiting supply and delaying order shipment, says the analyst. Further, Marcus points out that sales guidance for 2020 came in softer than expected at $1.0B-$1.1B versus expectations for closer to $1.14B based on his conversations. Though a disappointing close to 2019, the issues that stifled Q4 growth are transient in nature due to manufacturing, rather than a demand issue, contends the analyst. He also sees paths to upside in 2020 as SmileDirectClub "continues to enter high-growth, low-penetration international markets, expands its portfolio of products, and enters new channels."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
CareDx announces publication on AlloSure's ability on ambiguous rejections » 07:44
02/26/20
02/26
07:44
02/26/20
07:44
CDNA

CareDx

$25.04 /

-1.5 (-5.65%)

CareDx announces that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Salesforce price target raised to $220 from $210 at Stifel » 07:42
02/26/20
02/26
07:42
02/26/20
07:42
CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

Stifel analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Stratasys sees FY20 EPS 45c-60c, consensus 63c » 07:42
02/26/20
02/26
07:42
02/26/20
07:42
SSYS

Stratasys

$18.28 /

-0.82 (-4.29%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Fossil sees 2020 net sales decline 4.5%-11%, two est. $2.15B  07:42
02/26/20
02/26
07:42
02/26/20
07:42
FOSL

Fossil

$5.31 /

-0.14 (-2.57%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.